Загрузка...
Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults.
In a randomized, double-blind trial involving patients with uncomplicated influenza A H3N2 subtype virus infection, rimantadine treatment (200 mg/day for 5 days) was associated with significant reductions in nasal secretion viral titers (days 2 through 4), maximal temperature (days 2 and 3), time un...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1986
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC176405/ https://ncbi.nlm.nih.gov/pubmed/3521480 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|